Cyclooxygenase-2: A therapeutic target

Marco E. Turini, Raymond N. DuBois

    Research output: Contribution to journalReview articlepeer-review

    517 Scopus citations

    Abstract

    Cyclooxygenase (COX), also known as prostaglandin endoperoxide synthase, is the key enzyme required for the conversion of arachidonic acid to prostaglandins. Two COX isoforms have been identified, COX-1 and COX-2. In many situations, the COX-1 enzyme is produced constitutively (e.g., in gastric mucosa), whereas COX-2 is highly inducible (e.g., at sites of inflammation and cancer). Traditional nonsteroidal anti-inflammatory drugs (NSAIDs) inhibit both enzymes, and a new class of COX-2 selective inhibitors (COXIBs) preferentially inhibit the COX-2 enzyme. This review summarizes our current understanding of the role of COX-1 and COX-2 in normal physiology and disease.

    Original languageEnglish (US)
    Pages (from-to)35-57
    Number of pages23
    JournalAnnual Review of Medicine
    Volume53
    DOIs
    StatePublished - Mar 9 2002

    Keywords

    • Biology
    • Cyclooxygenase
    • Disease
    • Inflammation
    • Prostaglandins

    ASJC Scopus subject areas

    • Biochemistry, Genetics and Molecular Biology(all)

    Fingerprint

    Dive into the research topics of 'Cyclooxygenase-2: A therapeutic target'. Together they form a unique fingerprint.

    Cite this